Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial.
Verweij ME, Tanaka MD, Kensen CM, van der Heide UA, Marijnen CAM, Janssen T, Vijlbrief T, van Grevenstein WMU, Moons LMG, Koopman M, Lacle MM, Braat MNGJA, Chalabi M, Maas M, Huibregtse IL, Snaebjornsson P, Grotenhuis BA, Fijneman R, Consten E, Pronk A, Smits AB, Heikens JT, Eijkelenkamp H, Elias SG, Verkooijen HM, Schoenmakers MMC, Meijer GJ, Intven M, Peters FP. Verweij ME, et al. Among authors: intven m. BMJ Open. 2023 Jun 15;13(6):e065010. doi: 10.1136/bmjopen-2022-065010. BMJ Open. 2023. PMID: 37321815 Free PMC article.
Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands.
Nijkamp J, de Haas-Kock DF, Beukema JC, Neelis KJ, Woutersen D, Ceha H, Rozema T, Slot A, Vos-Westerman H, Intven M, Spruit PH, van der Linden Y, Geijsen D, Verschueren K, van Herk MB, Marijnen CA. Nijkamp J, et al. Among authors: intven m. Radiother Oncol. 2012 Jan;102(1):14-21. doi: 10.1016/j.radonc.2011.08.011. Epub 2011 Sep 6. Radiother Oncol. 2012. PMID: 21903287
RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial.
Burbach JP, Verkooijen HM, Intven M, Kleijnen JP, Bosman ME, Raaymakers BW, van Grevenstein WM, Koopman M, Seravalli E, van Asselen B, Reerink O. Burbach JP, et al. Among authors: intven m. Trials. 2015 Feb 22;16:58. doi: 10.1186/s13063-015-0586-4. Trials. 2015. PMID: 25888548 Free PMC article. Clinical Trial.
The impact of postoperative complications on health-related quality of life in older patients with rectal cancer; a prospective cohort study.
Couwenberg AM, de Beer FSA, Intven MPW, Burbach JPM, Smits AB, Consten ECJ, Schiphorst AHW, Wijffels NAT, de Roos MAJ, Hamaker ME, van Grevenstein WMU, Verkooijen HM. Couwenberg AM, et al. Among authors: intven mpw. J Geriatr Oncol. 2018 Mar;9(2):102-109. doi: 10.1016/j.jgo.2017.09.005. Epub 2017 Oct 10. J Geriatr Oncol. 2018. PMID: 29032962 Free article.
Tolerability, Safety, and Outcomes of Neoadjuvant Chemoradiotherapy With Capecitabine for Patients Aged ≥ 70 Years With Locally Advanced Rectal Cancer.
Jacobs L, van der Vlies E, Ten Bokkel Huinink D, Bloemendal H, Intven M, Smits AB, Weusten BLAM, Siersema PD, van Lelyveld N, Los M. Jacobs L, et al. Among authors: intven m. Clin Colorectal Cancer. 2018 Sep;17(3):179-186. doi: 10.1016/j.clcc.2018.03.004. Epub 2018 Mar 8. Clin Colorectal Cancer. 2018. PMID: 29661620
Effect of Neoadjuvant Therapy and Rectal Surgery on Health-related Quality of Life in Patients With Rectal Cancer During the First 2 Years After Diagnosis.
Couwenberg AM, Burbach JPM, van Grevenstein WMU, Smits AB, Consten ECJ, Schiphorst AHW, Wijffels NAT, Heikens JT, Intven MPW, Verkooijen HM. Couwenberg AM, et al. Among authors: intven mpw. Clin Colorectal Cancer. 2018 Sep;17(3):e499-e512. doi: 10.1016/j.clcc.2018.03.009. Epub 2018 Mar 21. Clin Colorectal Cancer. 2018. PMID: 29678514 Free article.
119 results